Access in Abu Dhabi, UAE
Middle East ยท Tier 1
Regulatory framework
Abu Dhabi runs the emirate-level Named Patient / compassionate-use pathway through Department of Health Abu Dhabi (DoH), coordinated with the federal Ministry of Health and Prevention (MoHAP) where required. Abu Dhabi-licensed physicians apply on behalf of individual patients for drugs not registered in-country or not stocked at the dispensing facility. Tertiary hospitals such as Cleveland Clinic Abu Dhabi, Sheikh Khalifa Medical City, and NMC Royal Hospital use this workflow routinely.
Case active and ready to skip the regulatory walkthrough? Start your case or WhatsApp us.
Typical timeline
For patients in Abu Dhabi requesting a specialty drug through Reserve Meds, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.
What a typical process looks like
- Patient or physician submits a request with drug name and indication.
- We verify clinical appropriateness and document eligibility.
- Treating physician issues prescription and clinical justification.
- Country-specific regulatory documentation is prepared and submitted.
- Patient pre-pays; we source via DSCSA-compliant US wholesaler.
- Drug ships cold-chain to destination physician or hospital pharmacy.
- Physician receives, confirms storage, and begins treatment.
Popular drug requests from Abu Dhabi
Lenmeldy
Metachromatic leukodystrophy
Kresladi
Leukocyte adhesion deficiency I
Elevidys
Duchenne muscular dystrophy
Lyfgenia
Sickle cell disease
Zevaskyn
Recessive DEB
Skysona
Cerebral adrenoleukodystrophy
Casgevy
Sickle cell disease; transfusion-dependent beta-thalassemia
Ryoncil
Pediatric SR-aGvHD
Tecelra
Synovial sarcoma
Encelto
Macular telangiectasia type 2
Qfitlia
Hemophilia A/B prophylaxis
Vyjuvek
Dystrophic epidermolysis bullosa